Company to Host Webcast Wednesday, April 13, 2022 at 11am ETWALTHAM, Mass., April 07, 2022(NASDAQ: NERV), a clinical-stage biopharmaceutical company developing therapies to treat central nervous system
Minerva Neurosciences Announces Promotion of Geoff Race to President streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Operator
Welcome to Minerva Neurosciences year-end 2020 conference call. [Operator instructions] There will be a question-and-answer session following today s prepared remarks. This call is being webcast live on the investor section of Minerva s website at ir.minervaneurosciences.com. As a reminder, today s call is being recorded.
I would now like to turn the call over to William Boni, vice president of investor relations and corporate communications at Minerva. Please proceed.
William Boni
Vice President of Investor Relations and Corporate Communications
Good morning. A press release for the company s fourth-quarter and year-end 2020 financial results and business highlights became available at 7:30 Eastern time today and can be found on the investor section of our website. Our annual report on Form 10-K was also filed electronically with the Securities and Exchange Commission this morning and can be found on the SEC s website at www.sec.gov. Joining me on the call today fro
EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
Mon, 1st Mar 2021 16:41
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:
Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Moves Chief Investment Officer Richard Pye to chief financial officer and executive director, while interim CFO Michael Norris moves to non-executive director, both from last Friday. Norris has been interim CFO since March last year. Additionally, Geoff Race joins the board as non-executive director. Race is co-founder and CFO of Nasdaq-listed biopharmaceutical company Minerva Neurosciences Inc.